Skip to main content Skip to navigation
FITC Mouse Anti-Human CD33
제품 세부 정보
Down Arrow Up Arrow


BD™
CD33 FITC P67.6 50 Tests RUO/GMP
Siglec-3; SIGLEC3; Sialic acid-binding Ig-like lectin 3; p67; gp67; My9
Human
Mouse BALB/c IgG1, κ
CD33-transfected FMY9S5 Cells
Flow cytometry
3 μg/mL
20 μL
IV M503
945
AB_400047
Phosphate buffered saline with gelatin and 0.1% sodium azide.
RUO (GMP)


준비 및 보관

The monoclonal antibody is supplied as 12 μg purified immunoglobulin in 2.0 mL (6 μg/mL) of phosphate-buffered saline (PBS). The FITC conjugate is supplied as 3 μg in 1.0 mL (3 μg/mL) of PBS. The PE conjugate is supplied as 24 μg in 2.0 mL (12 μg/mL) of PBS. The PerCP-Cy5.5 conjugate is supplied as 6.3 μg in 1.0 mL (6.3 μg/mL) of PBS. The PE-Cy7 conjugate is supplied as 12.5 μg in 0.5 mL (25 μg/mL) of PBS. The APC conjugate is supplied as 6.2 μg in 0.5 mL (12.4 μg/mL) of PBS. PBS contains gelatin and 0.1% sodium azide.

Store vials at 2° to 8°C. Conjugated forms should not be frozen and should be protected from prolonged exposure to light. Each reagent is stable for the period shown on the bottle label when stored as directed.

340533 Rev. 1
항체 세부 정보
Down Arrow Up Arrow
P67.6

The CD33 antibody, clone P67-6, is derived from the hybridization of Sp2/0 mouse myeloma cells with spleen cells isolated from BALB/c mice immunized with FMY9S5 cells containing the CD33 gene.

The CD33 antibody recognizes a human myelomonocytic antigen, with a molecular weight of 67 kilodaltons (kDa).

340533 Rev. 1
형광 세부 정보
Down Arrow Up Arrow
FITC
Fluorescein (FITC) is part of the BD blue family of dyes. This is a small organic fluorochrome with an excitation maximum (Ex Max) at 494-nm and an emission maximum (Em Max) at 518-nm. FITC is designed to be excited by the Blue laser (488-nm) and detected using an optical filter centered near 520 nm (e.g., a 530/30-nm bandpass filter). Please ensure that your instrument’s configurations (lasers and optical filters) are appropriate for this dye.
altImg
FITC
Blue 488 nm
494 nm
518 nm
340533 Rev.1
인용 및 참고 문헌
Down Arrow Up Arrow

개발 참고 자료 (7)

  1. Andrews RG, Takahashi M, Segal GM, Powell JS, Bernstein ID, Singer JW. The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood. 1986; 68:1030-1035. (Biology).
  2. Andrews RG, Torok-Storb B, Bernstein ID. Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies.. Blood. 1983; 62(1):124-32. (Biology). 참조 보기
  3. Bernstein ID, Singer JW, Andrews RG, et al. Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.. J Clin Invest. 1987; 79(4):1153-9. (Biology). 참조 보기
  4. Dinndorf PA, Andrews RG, Benjamin D, Ridgway D, Wolff L, Bernstein ID. Expression of normal myeloid-associated antigens by acute leukemia cells.. Blood. 1986; 67(4):1048-53. (Biology). 참조 보기
  5. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma.. Blood. 1986; 68(1):1-31. (Biology). 참조 보기
  6. Köller U, Peschel CH. Knapp W, Dörken B, Gilks WR, et al, ed. Leucocyte Typing IV: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1989:812-813.
  7. Terstappen LW, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol. 1990; 48(2):138-148. (Biology). 참조 보기
모두 보기 (7) 간단히 보기
340533 Rev. 1

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures. 

 

Although not required, these products are manufactured in accordance with Good Manufacturing Practices.